Skip to main content
. 2019 Nov 13;93(23):e00664-19. doi: 10.1128/JVI.00664-19

TABLE 1.

Primary antibodies used in this study

Primary antibodya Source or reference Catalog no.
Mouse anti-human CD11c (BV710, clone B-Ly6) BD Biosciences 563130
Mouse anti-human HLA-DR (PE-CF594, clone G46-6) BD Biosciences 562304
Mouse anti-human CD1a (BV421, clone HI149) BioLegend 300128
Mouse anti-human CD209 (PE, clone 9E9A8) BioLegend 330106
Mouse anti-human CD14 (PE, clone M5E2) BioLegend 301806
Mouse anti-human CD80 (AF488, clone 2D10) BioLegend 305214
Mouse anti-human CD86 (BV605, clone IT2.2) BioLegend 305430
Mouse anti-human CD40 (PE-Cy7, clone 5C3) BioLegend 334322
Mouse anti-human CD3 (BUV496, clone UCHT1) BD Biosciences 564809
Mouse anti-human CD4 (FITC, clone A161A1) BioLegend 357406
Mouse anti-human CD8 (FITC, clone HIT8a) BioLegend 300906
Mouse anti-human HLA-DR (AF700, clone L243) BioLegend 307626
Mouse anti-human CD38 (BUV395, clone HIT2) BD Biosciences 740294
Unconjugated monoclonal humanized E16 antibody 17
a

PE, phycoerythrin; FITC, fluorescein isothiocyanate.